VTYX
VTYX
NASDAQ · Pharmaceuticals

Ventyx Biosciences Inc

$14.00
+0.02 (+0.14%)
Analyst Consensus
Hold
15
Analysts
High
Coverage
Buy 6 40%
Hold 9 60%
Sell 0 0%
Price Target
Analyst Price Target +351.1% upside
Low Target $39.88
Average Target $63.16
High Target $74.20
Current Price $14.00
Current
$14.00
Target
$63.16
$39.88 $63.16 avg $74.20
Scenario Analysis
Bear Case
$39.88
184.9%
Low target
Base Case
$63.16
+351.1%
Avg target
Bull Case
$74.20
+430.0%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$25.00
-44.0% from high
52-Week Low
$7.08
+97.7% from low
Target vs 52W High
$63.16
+152.6% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 37 86% $1,330.33 -6.5%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 70% $299.55 +6.2%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 34 38% $33.90 +15.9%
BMY
Bristol-Myers Squibb Co
Hold 34 41% $174.50 +180.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -47.3%
ZTS
Zoetis Inc
Hold 22 41% $209.87 +156.1%